MARKET

SNCA

SNCA

Seneca Biopharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.080
-0.090
-7.69%
After Hours: 1.060 -0.02 -1.85% 19:42 01/24 EST
OPEN
1.200
PREV CLOSE
1.170
HIGH
1.200
LOW
1.050
VOLUME
898.00K
TURNOVER
--
52 WEEK HIGH
13.78
52 WEEK LOW
0.7000
MARKET CAP
3.04M
P/E (TTM)
-0.1837
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of SNCA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

EPS

SNCA News

  • Seneca Biopharma rockets 129% on cell therapy promise
  • seekingalpha.01/17 22:42
  • Seneca Biopharma Announces Exercise of Warrants for $7.55 Million Gross Proceeds Priced At-the-Market
  • Benzinga.01/17 19:00
  • Seneca Biopharma Announces Exercise of Warrants for $7.55 Million Gross Proceeds Priced At-the-Market
  • PR Newswire.01/17 19:00
  • Seneca Biopharma Announces Presentations at Both Sachs Associates 3rd Annual Neuroscience Innovation Forum & Biotech Showcase 2020
  • PR Newswire.01/10 16:00

More

Industry

Biotechnology & Medical Research
-2.64%
Pharmaceuticals & Medical Research
-2.00%

Hot Stocks

Name
Price
%Change

About SNCA

Seneca Biopharma, Inc., formerly Neuralstem, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for diseases of unmet medical need. It is focused on finding and acquiring new assets, sciences and technologies that provide therapies for patients. It intends to focus on developing a pipeline of biopharmaceuticals and commercializing those products.
More

Webull offers Seneca Biopharma Inc (SNCA) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.